Fluvoxamine for the treatment of COVID‐19

Overview of attention for article published in Cochrane database of systematic reviews, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs: 1 blog
twitter: 38 X users

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 120 Mendeley

Summary Blogs X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 blog post.

End of year message from Cochrane's CEO, Catherine Spencer

Cochrane in the News, 20 Dec 2022

Dear Cochrane Colleagues, Members and Supporters, Thank you to everyone across our community for your dedication and…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.